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We report a lung-on-a-chip array that mimics the pulmonary parenchymal environment, including the thin
alveolar barrier and the three-dimensional cyclic strain induced by breathing movements. The
micro-diaphragm used to stretch the alveolar barrier is inspired by the in vivo diaphragm, the main
muscle responsible for inspiration. The design of this device aims not only at best reproducing the in vivo
conditions found in the lung parenchyma but also at making the device robust and its handling easy. An
innovative concept, based on the reversible bonding of the device, is presented that enables accurate
control of the concentration of cells cultured on the membrane by easily accessing both sides of the
membranes. The functionality of the alveolar barrier could be restored by co-culturing epithelial and
endothelial cells that form tight monolayers on each side of a thin, porous and stretchable membrane.
We showed that cyclic stretch significantly affects the permeability properties of epithelial cell layers.
Furthermore, we also demonstrated that the strain influences the metabolic activity and the cytokine
secretion of primary human pulmonary alveolar epithelial cells obtained from patients. These results
demonstrate the potential of this device and confirm the importance of the mechanical strain induced by
breathing in pulmonary research.Introduction
The pharmaceutical sector is currently experiencing a serious
efficiency crisis that forces all of the actors in this field to
rethink the way research and development can be performed
more efficiently.1 One of the key issues that urgently needs to
be addressed is the lack of efficient and reproducible drug
discovery models able to predict the toxicity and the efficiency
of compounds in humans prior to launching expensive clini-
cal trials. Animal models used in the preclinical phase often
poorly predict the toxicological responses in humans2 and
standard in vitro models fail to reproduce the complexity of
the biophysical and cellular microenvironment found in vivo.
Recent progress in microtechnologies has enabled theemergence of novel in vitro models that better reproduce the
in vivo conditions.3 These models called “organs-on-chips” are
widely seen as being able to better predict human responses
and simultaneously to importantly reduce the ethically contro-
versial animal testing.
Lungs-on-chips aiming at mimicking the complex micro-
environment of the lung alveoli have only recently been
reported. In sharp contrast to standard in vitro models, such
systems allow the reproduction of cyclic mechanical stress
induced by respiratory movements. Takayama and col-
leagues investigated the mechanical stress induced by liquid
plug propagation in small flexible airway models and
suggested that the possibility of induced injuries on lining
cells along the airways in emphysema is higher due to larger wall
stresses.4 His group further studied the combined effect of
mechanical and surface tension stresses that typically occur
in ventilator induced lung injury.5 Using this device, they
demonstrated cellular-level lung injury under flow conditions
that caused symptoms characteristic of a wide range of pul-
monary diseases.6More recently, Ingber and colleagues reported
a lung alveoli model that further reproduces the in vivo situa-
tion by mimicking the thin alveolar barrier being cyclically
stretched.7 The barrier, made of a thin, porous and stretch-
able polydimethylsiloxane (PDMS) membrane on which epi-
thelial and endothelial cells are cultured, is sandwichedoyal Society of Chemistry 2015
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View Article Onlinebetween two microfluidic structures creating two superposed
microchannels. Actuation resulting in the cyclic strain of the
PDMS membrane is performed by varying the negative pres-
sure in the two channels located on each side of the super-
posed microchannels and separated from it by thin walls.
This actuation principle presents the drawback that the strain
applied to the thin, porous membrane strongly depends on
the viscoelastic properties of the stretched material (here
PDMS) and on the dimensions, in particular the thickness, of
the thin PDMS walls. Consequently, the negative pressure
applied to the adjacent channels needs to be precisely con-
trolled. In addition, the typical confined microfluidic setting
used does not allow the precise control of the concentration
of cells seeded on the membrane.
Furthermore, the in vivo relevance of almost all in vitro
human lung alveoli models is limited by the use of lung epi-
thelial cell lines or primary lung cells from rats. Unfortu-
nately, the most used lung epithelial cells, A549, is a lung
adenocarcinoma cell line that poorly mimics the phenotype
of original pulmonary alveolar epithelial cells. On the other
hand, primary lung cells from rats suffer from interspecies
differences and are thus inadequate to recreate the human
air–blood barrier.
We report here a novel lung-on-a-chip that does not
suffer from these limitations. It mimics the lung alveolar bar-
rier in an unprecedented way, using primary human pulmo-
nary alveolar epithelial cells obtained from patients who
underwent partial lung resection. The lung alveolar barrier
can be exposed to a 3D cyclic mechanical strain using a
novel bioinspired actuation mechanism. Experiments per-
formed with those cells and lung bronchial epithelial cells
revealed the significance of the mechanical strain on those
cells. This robust and easy to use lung-on-a-chip is intended
to be a tool for drug discovery development as well as for
toxicology fields in research and industry.This journal is © The Royal Society of Chemistry 2015
Fig. 1 Working principle and design of the lung-on-a-chip. (A) In vivo, insp
three-dimensional expansion of the alveolar sacs. (B) In vitro, the 3D cyclic
a micro-diaphragm (b) that is actuated by an electro-pneumatic set-up. Th
able membrane on which epithelial and endothelial cells are cultured. (C) T
The fluidic part consists of three alveolar cell culture wells (i) and thin, poro
are located (iii). The micro-diaphragms (iv) are integrated into the pneumat
of the lung-on-a-chip filled with food-dye-colored solutions inside the basMaterials and methods
Fabrication of the lung-on-a-chip
The lung-on-a-chip consists of a fluidic part and a pneumatic
part (Fig. 1C). The fluidic part comprises two PDMS plates
between which a thin, porous and flexible PDMS membrane
is sandwiched and bonded. The top plate contains a 3 mm
diameter access hole on the apical side of the membrane and
a 1 mm diameter hole to access the overflow chamber. The
bottom plate is structured with a cell culture medium
reservoir. The pneumatic part is made of a 40 μm thin PDMS
layer bonded with the actuation plate in which pneumatic
channels are structured. The fluidic and pneumatic parts
were made by soft lithography.8 Briefly, the PDMS base and
curing agents (Sylgard 184, Dow Corning) were mixed well
(10 : 1 w/w ratio), degassed in a vacuum desiccator and casted
in hard plastic molds made directly from aluminum molds
structured by standard machining (ki-Mech GmbH). The
PDMS pre-polymer was cured at 60 °C for at least 24 hours.
The porous and flexible membrane was fabricated by a
microstructuring–lamination process. The PDMS pre-polymer
was sandwiched between a silicon mold containing an array
of micropillars structured by DRIE and a 75 μm thin PE sheet
(DuPont Teijin Films, Melinex® 411). The micropillars have
different heights ranging from 3.5 μm up to 10 μm and
different diameters (3 μm or 8 μm) that define the final
thickness and the pore size of the membrane. The silicon
mold and the plastic sheet were then clamped together with
the PDMS pre-polymer sandwiched in between and cured at
60 °C for at least 24 hours. The thickness of the produced
membrane corresponds to the height of the micropillars,
which have pores of 3 or 8 μm in diameter (Fig. 2A). After
curing, themembrane was released from themold and irrevers-
ibly bonded by O2 plasma (Harrick Plasma) onto the bottom
plate. The top plate was then reversibly bonded to the bottomLab Chip, 2015, 15, 1302–1310 | 1303
iration is controlled by the diaphragm, whose contraction leads to the
mechanical strain of the bioartificial alveolar membrane (a) induced by
e bioartificial alveolar membrane consists of a thin, porous and stretch-
he lung-on-a-chip is made of 25 × 75 mm fluidic and pneumatic parts.
us and flexible membranes (ii), beneath which the basolateral chambers
ic part and connected to pneumatic microchannels (v). (D) Photograph
olateral chambers. Scale bar: 10 mm.
Fig. 2 Porous and flexible PDMS membrane used as a cell culture substrate. (A) SEM image of a PDMS membrane with 8 μm pores. (B)
Z-projection of a confluent layer of lung epithelial cells (16HBE14o−) stained for adherens junction E-cadherin (red) and for cell nuclei (blue). The
pores of the porous membrane can be seen in the background. (C) Immunofluorescence image of endothelial cells (HUVEC) stained for adherens
junction VE-cadherin (green) and for cell nuclei (blue). (D) Confocal picture of the 16HBE14o− and HUVEC co-culture, stained for E-cadherin (red),
VE-cadherin (green) and cell nuclei (blue). Cell–cell contacts between the epithelial and endothelial cells can be seen through the pores. Scale
bars: 50, 50, 20 and 30 μm.
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View Article Onlineplate. The thin PDMS layer in which the micro-diaphragm is
included was fabricated by spinning the PDMS pre-polymer
onto a PE sheet attached to a silicon wafer at 1700 rpm for
60 seconds. After spinning, the membrane was allowed to
cure for 24 hours at 60 °C and was then irreversibly bonded
by O2 plasma to the actuation plate.Cell culture protocols
Bronchial epithelial 16HBE14o− cells (from Dr. Gruenert of
the University of California, San Francisco) were cultured in
MEM medium (Gibco) supplemented with 10% FBS (Gibco),
1% L-glutamine (2 mM, Gibco), 1% penicillin (100 U ml−1,
Gibco) and 1% streptomycin (100 U ml−1, Gibco). Primary
human pulmonary alveolar epithelial cells (pHPAEC) were
obtained from a lung resection from a patient undergoing
pneumonectomy for lung cancer. All participants provided
written informed consent. Briefly, healthy lung tissue was
digested into a single cell suspension using a solution of 0.1%
collagenase I/0.25% collagenase II (Worthington Biochemicals).
Healthy epithelial cells were isolated using fluorescence
activated cell sorting (BD FACSAria III) with an antibody that
recognizes CD326, also known as the epithelial cell adhesion
molecule (EpCAM, clone 1B7, eBioscience), while excluding
hematopoietic (CD45, clone 2D1 and CD14, clone 61D3,
eBioscience) and endothelial cells (CD31, clone WM59,
eBioscience). Following sorting, EpCAM+ primary human
pulmonary alveolar epithelial cells (pHPAECs) were cultured
for expansion in CnT-Prime Airway epithelial culture medium
(CELLnTEC, Berne, CH) supplemented with 1% penicillin
(100 U ml−1, Gibco) and 1% streptomycin (100 U ml−1, Gibco),
1% Pen Strep (Gibco). Immunophenotyping of culture-
expanded EpCAM+ cells was carried out using flow cytometry
(BD FACSCanto LSRII) for the expression of the type I and type
II epithelial markers podoplanin (clone NZ-1.3, eBioscience)
and CD63 (clone H5C6, eBioscience), respectively. Primary
human umbilical vein endothelial cells (pHUVEC, Lonza)
were cultured in EBM-2 medium (Lonza) supplemented with
2% FBS and growth factors according to the manufacturer's1304 | Lab Chip, 2015, 15, 1302–1310protocol. All cells were maintained at 37 °C, 5% CO2
in air. Prior to cell seeding, the microfluidic devices were
sterilized by ozone (CoolCLAVE, Genlantis) and the porous
membranes were covalently coated with human fibronectin
(2.5 μg cm−2, Merck Millipore) or 0.1% gelatin and 2 μg ml−1
collagen I as previously described.9 Briefly, the membranes
were activated by O2 plasma and immediately covered with
5% Ĳ3-aminopropyl)triethoxysilane (Sigma-Aldrich) in H2O.
After 20 min, the membranes were thoroughly rinsed with
deionized water and covered with 0.1% glutaraldehyde
(Sigma-Aldrich). After an additional 20 min incubation, the
membranes were washed again with deionized water, and
then coated with fibronectin and incubated overnight. Prior
to cell seeding, the membranes were washed with cell culture
medium.
Co-culture experiments. pHUVECs (passage 4) were seeded
on the basal side of the membrane at 5 × 104 cells cm−2 on a
10 μm thin membrane with 8 μm pores (6 × 104 pores cm−2). After
24 h, the lung-on-a-chip was flipped and epithelial cells were
seeded on the apical side of the membrane at 4 × 105 cells cm−2.
The cells were allowed to adhere and grow for 24 h before
being stained for fluorescence imaging.
Cell permeability. 16HBE14o− bronchial epithelial cells
were used for cell permeability experiments between passages
2.50 and 2.57. They were seeded at a density of 2.5 × 105
cells cm−2 on 10 μm thin, porous PDMS membranes (8 μm
pores, 6 × 104 pores cm−2). The cells were allowed to adhere for
two hours, and then the cell culture medium was replenished.
The cells were cultured for 72 h before being used for the
permeability assay to ensure confluence. The cell culture
medium was replenished daily.
Cell viability and cytokine expression. Cell culture expanded
EpCAM+ pHPAECs (passage 3) were used for the cell viability
assays as well as for the IL-8 secretion experiments. Cells
were seeded on a 3.5 μm thin PDMS membrane without
pores at a density of 4 × 105 cells cm−2. The cells were allowed
to adhere for 24 h before the cell culture medium was
replenished. The cells were grown for 48 h prior to use. The
cell culture medium was changed daily.This journal is © The Royal Society of Chemistry 2015
Lab on a Chip Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
3 
D
ec
em
be
r 2
01
4.
 D
ow
nl
oa
de
d 
on
 2
6/
11
/2
01
5 
08
:5
0:
54
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineStretching protocol
Once a confluent cell monolayer is formed on the thin mem-
brane, a drop of 50 μl of cell culture medium is added to the
basal side of the fluidic part. The fluidic part is then flipped
with the drop of cell culture medium hanging and mounted
onto the pneumatic part. The micro-diaphragm is able to
apply a reproducible three-dimensional cyclic strain to the
cells (corresponding to 10% linear strain). To cyclically
stretch the membrane at a frequency of 0.2 Hz, the lung-on-
a-chip is connected to an external electro-pneumatic setup.
This setup controls the magnitude of the applied negative
pressure as well as the frequency. The pressure-curve is
modeled as a sinusoidal wave. A 10% linear stretch magni-
tude is within the physiological range of strain, experienced
by the alveolar epithelium in the human lung.10Permeability assay
Upon confluence (after 72 hours in culture), the basal com-
partment was filled with cell culture medium and mounted
on the pneumatic part. The cells were either preconditioned
by stretching for 19 hours or kept under static conditions for
the same amount of time prior to performing the assay. To
assess the apical to basal permeability of the epithelial bar-
rier, 1 μg ml−1 FITC-sodium (Sigma Aldrich) in MEM medium
and 1 mg ml−1 RITC-dextran (70 kDa, Sigma-Aldrich) in MEM
medium were added from the apical side of the epithelial
barrier. The system was allowed to incubate for two hours
under either dynamic or static conditions. After two hours of
incubation, the fluid gained from the basal side of the barrier
was collected and analyzed with a multiwell plate reader
(M1000 Infinite, Tecan) at 460 nm and 553 nm excitation and
515 nm and 627 nm emission for FITC-sodium and RITC-dex-
tran, respectively. The permeability was assessed in terms of
relative transport across the epithelial barrier by normalizing
the fluorescence intensity signal obtained from the solution
sampled in the basal chamber with the fluorescence signal
obtained from the standard solution initially added to the
apical side of the barrier.Cell viability and proliferation
To measure cell viability and proliferation, the non-toxic
alamar blue (Invitrogen) assay was used according to the
manufacturer's protocol. Briefly, the alamar blue reagent was
mixed with cell culture medium in a 1 : 10 ratio. 60 μl of the
mixture was added to the cell culture well and incubated for
one hour at 37 °C under static conditions. After incubation,
the fluorescence intensity of the cell supernatant was mea-
sured using a multiwell plate reader at 570 nm excitation and
585 nm emission. The fluorescence intensity corresponds
directly to the metabolic activity of the cells. The assay was
performed at 0 h (before applying stretch) and after 24 h and
48 h of stretching. The same time points were used for the
static controls.This journal is © The Royal Society of Chemistry 2015IL-8 secretion
IL-8 secretion in the supernatant was measured using an
ELISA kit (R&D Diagnostics) according to the manufacturer's
protocol. The supernatant analyzed was collected after 2, 24
and 48 hours of stretching. After collection of the superna-
tant, new media were added. Cells kept under static condi-
tions served as control.
Immunofluorescence imaging
For immunofluorescence imaging, cells were rinsed with PBS
and fixed with 4% paraformaldehyde (Sigma-Aldrich) in PBS
for 12 min at room temperature. After several washing steps
with PBS, the cells were permeabilized with 0.2% Triton
X-100 (Sigma-Aldrich) in PBS for another 10 min. To prevent
any unspecific antibody binding, a blocking solution of PBS
with 5% FBS and 1% bovine serum albumin (Sigma-Aldrich)
was added for 30 min. Primary antibodies (E-cadherin (67A4),
Santa Cruz, and VE-cadherin (V1514), Sigma-Aldrich) were
diluted 1 : 100 in blocking solution and incubated for 2 h at
RT. The corresponding secondary antibodies (donkey anti-
mouse-AlexaFluor568, Invitrogen, and donkey anti-rabbit-
AlexaFluor488, Invitrogen), diluted 1 : 200, and Hoechst
33342 (1 : 10 000, Invitrogen) to counterstain cell nuclei were
incubated for 1 h at 20 °C in the dark. After rinsing three
times with blocking solution, the specimens were embedded
in Vectashield anti-fade medium (Sigma-Aldrich). Images
were obtained using a confocal laser scanning microscope
(CLSM, Zeiss LSM 710).
Statistics
Data are presented as mean ± standard deviation (SD). Differ-
ences between two means were determined by the two-tailed
unpaired Student's t-test and p < 0.05 was taken as the level
of significance.
Results and discussion
Design of the lung-on-a-chip with a bioinspired respiration
mechanism
The air–blood barrier of the lung, with a thickness of about 1
to 2 μm,11 is constantly exposed to cyclic mechanical stress
induced at the organ level by the diaphragm, the most impor-
tant muscle for inspiration. It consists of a thin dome shaped
sheet of muscle that contracts, thereby increasing the volume
of the thoracic cavity.12 The negative pressure created by the
diaphragm is further transmitted to the complex architecture
of the lung, up to its most delicate structures, the alveolar
sacs (Fig. 1A). Stress concentration is particularly important
in the thin alveolar septa that separate adjacent alveoli. This
site comprises two monolayers of alveolar epithelial cells sep-
arated by the basal membrane and pulmonary micro-
capillaries.10 During normal breathing, the respiratory cycle
consists of 10 to 12 breathings per minute, with mechanical
strain comprising between 5 and 12% linear elongation.10
The effects of mechanical strain have been reported in aLab Chip, 2015, 15, 1302–1310 | 1305
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View Article Onlinenumber of biological processes, for example in lung develop-
ment13,14 or in the evolution of various respiratory diseases,
such as acute lung injury,15 lung fibrosis16 and other intersti-
tial lung diseases.17 Although our knowledge of the
mechanobiology of the lung, in particular the mechano-
responses of lung epithelial cells, has advanced significantly
during the last two decades, much remains to be discovered
and understood in this research field.10 This fact is due in
large part to the lack of systems able to reproduce the
dynamic and structurally complex environment of the alveo-
lar barrier. Indeed, with the exception of the system recently
reported by Huh and colleagues,7 standard systems used to
investigate mechanical effects mimic only the respiratory
movements, but not the characteristics of the thin alveolar
barrier.10,18 In addition, the experimental conditions of all
these systems vary considerably making cross-comparisons
between studies difficult. This is particularly true for the
applied strain, which is applied in one direction (cell elonga-
tion, e.g. Huh et al.7), in two dimensions (stress of the cell
surface area, e.g. Flexcell) or in three dimensions, as in the
case in vivo and in the present lung-on-a-chip.
The design of the lung-on-a-chip presented in this study
mimics the alveolar sac environment of the human lung
including the mechanical stress induced by respiration move-
ments (Fig. 1A–B). The bioartificial alveolar barrier consists
of a thin, porous and flexible PDMS membrane on which
cells are cultured, typically epithelial cells on the apical side
and endothelial cells on the basal side of the membrane.
This barrier is indirectly stretched downwards by the move-
ments of a 40 μm thick actuation PDMS membrane that acts
as a micro-diaphragm. It is cyclically deflected by a negative
pressure applied in a small cavity located beneath the micro-
diaphragm. The cavity volume limits the deflection of the
micro-diaphragm enabling a clearly defined maximum strain
when the actuation membrane reaches the bottom of the cav-
ity. As the alveolar barrier and the micro-diaphragm are
located in a closed compartment filled with an incompress-
ible cell culture solution, the pressure applied on the micro-
diaphragm is transmitted to the alveolar membrane
according to Pascal's law. The maximum three-dimensional
mechanical strain applied – set at 10% linear strain – to the
alveolar membrane is thus accurately controlled by the vol-
ume of the micro-diaphragm cavity.
The reproduction of in vivo features is a priority to create
biologically relevant organs-on-chips. However the ease of
use and the robustness of such systems are parameters that
are as important in view of their broader use. The design of
the present lung-on-a-chip also addresses those constraints,
in particular the precise control of the number of cells
seeded in the culturing well, which is a typical and recurrent
issue of cell-based microfluidic systems. In such systems, the
cells loaded on the chip are not controlled once they enter
the microfluidic network, which often results in an inhomo-
geneous cellular spatial distribution and the “loss” of cells in
the fluidic network outside of the culturing zone. To address
this issue, a semi-open design was used which allowed1306 | Lab Chip, 2015, 15, 1302–1310accurate control of the cells seeded on the apical side of the
membrane (Fig. 1C–D). Cells are pipetted directly on the thin
membrane like in a standard multiwell plate. The problem of
cell seeding on the basal side of the membrane was solved by
using an extension of the hanging drop technique (ESI†
Fig. S1). Once the cell layer is confluent on the apical side of
the membrane, the chip is flipped and a drop of cell culture
medium with cells in suspension is added to the basal side
of the membrane. After cell adhesion on the basal side of the
membrane, the fluidic part of the lung-on-a-chip is flipped
with the cell culture medium drop hanging. The fluidic part
is then brought into contact with the lower part of the lung-
on-a-chip and closed. During this step, the drop of cell cul-
ture medium is forced into the basal compartment defined
between both plates. Excess solution is pushed outside of the
compartment via a microvalve.
The following results demonstrate in the first phase the
mechanical functionality and robustness of the lung-on-a-
chip. In the second phase, the effects of physiological
mechanical strain on lung epithelial cells were demonstrated.
The experiments were performed under normal breathing
conditions, meaning a breathing cycle of 12 cycles min−1, at a
physiological level of strain corresponding to 10% linear
elongation.Characterization of the lung-on-a-chip
Fig. 1C illustrates a bioinspired lung-on-a-chip with three
alveolar cell culture wells (i) each having direct access to a
thin, porous and stretchable alveolar membrane (ii). The
basal chambers (iii) located under each membrane are filled
with dyed solutions confined between the fluidic and the
pneumatic parts. The slight over deflection (about 1% linear
strain) of the alveolar membrane that results from bringing
the two parts together is levelled by a normally closed pneu-
matic microvalve located between the basal compartment
and the over-flow chamber. A slight pressure exerted on the
two rubber parts leads to reversible bonding (ESI† Fig. S1)
that is strong enough to ensure the operation of the chip as
well as to prevent any leakages. The cyclic mechanical stress
of the micro-diaphragm (iv) located in the pneumatic part of
the lung-on-a-chip enables the alveolar barrier to be mechani-
cally stressed at a well-defined level. The homemade electro-
pneumatic set-up, connected to the microchannels of the
pneumatic part (v), generates a negative pressure with a sinu-
soidal function that reproduces the respiration parameters
during normal breathing. The maximum strain in the alveo-
lar membrane is evaluated by comparing two pictures taken
in the center of the alveolar membrane at rest and when the
micro-diaphragm is completely deflected (ESI† Fig. S2). At
maximum deflection, the strain in the alveolar membrane
accounts for a maximal linear elongation of 10%.
The microstructuring–lamination process developed to
fabricate thin, porous and flexible membranes produces
reliable and reproducible features. The membranes can be
produced with thicknesses of either 3.5 or 10 μm and withThis journal is © The Royal Society of Chemistry 2015
Fig. 3 The effect of cyclic strain on the permeability of lung epithelial
16HBE14o− cells. The relative transport of a small molecule (FITC-
sodium) across the monolayer significantly increased upon a physiological
cyclic strain whereas the barrier integrity was not affected by the strain
(no significant transport increase for RITC-dextran). Cyclic stretch was
applied for 21 hours (dynamic, n = 3) and a control was kept under static
conditions (static,n=6) (mean values ± SD, p< 0.005).
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View Article Onlinepore sizes and densities of either 3 μm with 800 000 pores
cm−2 or 8 μm with 60 000 pores cm−2 with little variations in
pore densities (Fig. 2A). The pore sizes and densities of the
produced PDMS membrane correspond to those of commer-
cially available cell culture inserts.
Reconstitution of the lung alveolar barrier
The integrity of the lung alveolar barrier is one of the most
critical parameters of a healthy lung. Damaging it leads to
fluid infiltration into the alveolar sacs that may cause lung
edema and other types of pulmonary diseases. The integrity
of the barrier is guaranteed by a number of proteins forming
either tight junctions or adherens junctions. Tight junction
proteins are responsible for the formation of functional epi-
thelial and endothelial barriers and primarily function as a
diffusion barrier.19 Adherens junctions link actin filaments
between neighboring cells, maintain tissue integrity and
translate mechanical forces throughout a tissue via the
cytoskeleton.20
To recapitulate a functional epithelial barrier, a co-culture
of bronchial epithelial cells (16HBE14o−) and primary endo-
thelial cells (HUVEC) was cultured on a 10 μm thin, porous
membrane coated with fibronectin (Fig. 2D). HUVECs and
16HBE14o− bronchial epithelial cells were seeded on the
basal side and on the apical side of the membrane, respec-
tively. The epithelial and endothelial layers grew to conflu-
ence in two to four days building a homogeneous and tight
barrier. Tight junction proteins (e.g. zona occludens-1 (ZO-1))
and adherens junction proteins (e.g. E-cadherin) accumulated
at the cellular interface of the epithelial layer forming strong
cell–cell contacts (Fig. 2B). On the endothelial side, vascular
endothelial cadherin (VE-cadherin) based adherens junction
expression was also observed confirming the formation of a
tight endothelial barrier. The brush borders of the endothe-
lial cells are typical of endothelial layers (Fig. 2C). Cell–cell
contacts between the endothelial and epithelial layers could
also be confirmed through the 8 μm pores (Fig. 2D).
Influence of mechanical stress on barrier permeability
The alveolar epithelial barrier with its huge surface in contact
with air makes it one of the most important ports of entry in
the human body. The alveolar barrier is constantly exposed
to a variety of xenobiotics that are either cleared by the epi-
thelium or taken up by the air–blood barrier. A portion of
these molecules enter the bloodstream and are transported
to other organs, which they may then affect. Although it was
shown in different in vivo studies that the mechanical strain
highly affects the uptake of such molecules,21 only little is
known about the exact transport mechanisms taking place.22
The role of respiratory movements, in particular the dynam-
ics taking place in the tight junctions, is unknown and
requires the advent of novel devices enabling such
investigations.19
The lung-on-a-chip with a monolayer of bronchial epithe-
lial cells was used to investigate the effects of physiologicalThis journal is © The Royal Society of Chemistry 2015strain (10% linear) on the transport of specific molecules
across the epithelial barrier. A monolayer of bronchial epithe-
lial cells (16HBE14o−) was cultured on a fibronectin coated
porous PDMS membrane (8 μm pores). 16HBE14o− cells have
similar permeability properties to primary human alveolar
epithelial cells,23 which makes them a good model for perme-
ability studies. Furthermore, a monoculture of epithelial cells
was used to model transport within the lung because endo-
thelial cells have a much higher permeability24 and were
therefore neglected in this model. The permeability assays
were performed, either in static or in dynamic mode, with
two different molecules dispensed simultaneously to the
epithelial layer. The effect of physiological strain was
assessed based on the transport of hydrophilic molecules
(using FITC-sodium) and the epithelial barrier integrity
(RITC-dextran). The experiments revealed that the permeabil-
ity of small hydrophilic molecules is significantly (p < 0.005)
increased if the cells are kept in a dynamic environment (n = 3)
compared to a static environment (n = 6) (Fig. 3). The relative
increase in transport is about 46% (5.68 ± 0.52% vs. 3.88 ±
0.47%). This increase cannot be explained by the increase in
diffusive transport due to the stretching of the pores. In fact,
the diffusive transport scales linearly with the pore surface area,
which is 21% in the present case. In addition, the pore array is
covered by a confluent layer of cells. On the other hand, the
physiological strain did not affect the cell layer integrity, since
no significant increase of the permeability was observed for
RITC-dextran. This finding is supported by immunofluorescence
images of the 16HBE14o− cells, which did not show any signifi-
cant differences in morphology or in the tight junctions when
comparing the static and dynamic conditions (ESI† Fig. S3).
This experiment showed that the epithelial barrier per-
meability is significantly affected by the physiological strain
produced in the lung-on-a-chip. These results are in good
agreement with the increased permeability reported for
hydrophilic solutes in an in vivo study upon distention of
human lungs.25 The transport mechanism taking place is
not fully understood. The most accepted theory is that dueLab Chip, 2015, 15, 1302–1310 | 1307
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View Article Onlineto the stretching of the cells, the intercellular junction pores
are also stretched, which then leads to an enhanced perme-
ability of hydrophilic molecules.26 These results illustrate the
importance of investigating the effects of breathing motions
on the epithelial barrier permeability. Such issues are of
prime relevance to toxicology questions, as well as to
inhalable formulations that are expected to be developed in
the near future.27,28Influence of mechanical stress on the activity of primary
human pulmonary alveolar epithelial cells
Primary human pulmonary alveolar epithelial cells were
selected using the common epithelial marker EpCAM
(CD326). Following sorting, culture-expanded EpCAM+ cells
demonstrated a cuboidal morphology and expressed markers
that are typically found on type I and type II alveolar epithe-
lial cells in the lower airway (Fig. 4A, C). Expanded EpCAM+
pHPAECs were then cultured on thin, porous and flexible
membranes. The cells reached confluence after 24 h
(Fig. 4B). Further, the cells could be cultured for at least
21 days on the membranes.
To determine the influence of strain on the metabolic
activity of the pHPAECs, an alamar blue assay was performed
with static cells and cells before and after stretching
(Fig. 5A). Alamar blue measures the reductive potential of
the cells and is a measure of both cell proliferation and cell
viability. The fluorescence intensity of the cells under static
conditions almost doubled in the first 24 h, suggesting
that the cells are still proliferating (5239.5 ± 685.6 vs. 9391.7 ±
1513.3 a.u., n = 6). Similarly, the cells that were grown
under static conditions followed by 24 h of stretching almost
doubled their fluorescence intensity (5569.7 ± 655.6 vs.
10 728.7 ± 1147.3 a.u., n = 6). Therefore, 10% linear cyclic
stretch does not interfere with the proliferation of pHPAECs.
Furthermore, cyclic stretch of this magnitude does not increase
cell injury or cell death in primary human pulmonary alveolar1308 | Lab Chip, 2015, 15, 1302–1310
Fig. 4 Primary human pulmonary alveolar epithelial cells. (A) Representat
Phase-contrast picture of a confluent monolayer of EpCAM+ pHPAECs cult
density plots showing the expression of both type I (Pdpn-Percp-eFluor 710
cells. Pdpn, podoplanin; PB, Pacific Blue; ROI, region of interest.epithelial cells. However, if the cells are stretched for 48 h the
metabolic activity is significantly higher compared to the static
control (9860.2 ± 471 vs. 8164.8 ± 831.4 a.u., n = 6).
These findings are supported by the study of McAdams
et al., in which they exposed the human alveolar-like
adenocarcinomic cell line A549 to 16% linear strain.29 Similar to
our findings, they did not observe any significant difference
between cells stretched for 24 h and cells cultured under
static conditions. However, after 48 h of stretching, the prolif-
eration of the stretched cells was significantly enhanced.29
They also showed that cyclic strain with a magnitude of 16%
linear elongation did not change the percentage of dead cells
compared to a non-stretched control over 48 h. In contrast,
several studies with primary rat ATII cells showed a significant
increase in apoptosis and cell death even at linear stretch as
low as 6%.30,31 However, with our primary human pulmonary
alveolar cells we did not observe such a behavior. It is not
known whether these differences in the effect of stretching
on cell proliferation and viability are due to interspecies differences
or not.
The supernatant from pHPAEC cells under static and
dynamic conditions was further sampled at different time
points and analyzed for their cytokine release patterns.
Interleukin-8 (IL-8), a pro-inflammatory cytokine known to be
upregulated in cell lines upon mechanical stretching,32,33 was
measured by ELISA (Fig. 5B). After 2 h of stretching, no dif-
ference between dynamic and static conditions was observed
(0.71 ± 0.08 ng ml−1 vs. 0.58 ± 0.15 ng ml−1, n = 3). After 24 h
of stretching, a higher tendency of IL-8 secretion was seen
compared to the static control (10.97 ± 2.8 ng ml−1 vs. 6.54 ±
4.64 ng ml−1, n = 3). However, after 48 h of stretching, the
IL-8 concentration found in the supernatant of the stretched
cells was 2.5× higher than the IL-8 concentration in the static
control (9.7 ± 2.65 ng ml−1 vs. 3.81 ± 1.55 ng ml−1). The
knowledge of the effect of stretch on IL-8 production in the
lung is controversial and restricted to A549 cells only.
Two studies showed that IL-8 secretion is increased in A549This journal is © The Royal Society of Chemistry 2015
ive phase contrast image of culture expanded EpCAM+ pHPAECs. (B)
ured on the alveolar membrane (scale bar 200 μm). (C) Flow cytometric
) and type II (CD63-PB) surface markers on culture-expanded EpCAM+
Fig. 5 The effect of cyclic strain on the activity of primary human pulmonary alveolar epithelial cells. (A) The fluorescence intensity of alamar blue
increases similarly in the first 24 h under both conditions, static and stretched (dynamic), showing that the proliferation of primary alveolar epithelial
cells is not affected by cyclic stretch. However, after 48 h of stretching the metabolic activity is significantly higher in the stretched cells than in
the static control (n = 6, mean values ± SD, *p < 0.05). (B) The IL-8 secretion of primary alveolar cells being stretched (dynamic) compared to that
of a static control (static). After 24 hours of cyclic strain there is a tendency to an increased secretion of IL-8. After 48 hours the secretion of IL-8 is
significantly higher compared to that of the static control (n = 3), mean values ± SD, p < 0.001.
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View Article Onlinealready after 5 min to 4 h with low linear stretch of 2% and
5%, respectively.34,35 In contrast, several studies did not see
this increase in IL-8 production in A549 cells in the first few
hours even with a stretch magnitude of 10%.36,37 In our
study, we did not observe an increase after 2 h in primary
human pulmonary alveolar cells either. Jafari et al. only
found higher IL-8 production when stretching the cells with
a linear elongation of 15%.36 Ning & Wang further showed
stretch magnitude dependent IL-8 secretion, which does not
depend on the stretch frequency.35 The only study looking at
longer periods of stretching (up to 48 h) observed an increase
of IL-8 production in A549 when stretched at 30% linear
stretch, but not when stretched at 20% linear stretch.33 To
our knowledge, our study shows for the first time that over
longer periods of stretching, IL-8 secretion is enhanced in
primary human pulmonary alveolar epithelial cells.
Conclusion
To better model the in vivo conditions of the biophysical and
cellular microenvironment, new and more accurate in vitro
models are needed. Unlike standard cell cultures, organs-on-
chips are widely seen as promising candidates capable of
predicting human responses to drugs.
This bioinspired lung-on-a-chip mimics the microenviron-
ment of the lung parenchyma by reproducing the thin alveo-
lar barrier constantly exposed to respiratory movements.
A flexible, thin and porous membrane, on which a co-culture
of epithelial and endothelial cells is cultured, is cyclically
deflected by a micro-diaphragm, whose function is similar to
that of the in vivo diaphragm. The effects of breathing
movements were investigated using a bronchial epithelial
cell line as well as primary human lung epithelial cells from
patients. With this device we could demonstrate that the
mechanical stress profoundly and significantly affects theThis journal is © The Royal Society of Chemistry 2015epithelial barrier permeability. In addition, the metabolic
activity of primary human pulmonary alveolar epithelial cells
cultured in dynamic mode was found to be significantly
higher than that of cells cultured in static mode. Similarly, a
significantly higher production of the inflammation marker
IL-8 was found in these cells. To the best of our knowledge,
this is the first time that the effects of mechanical strain on
healthy human primary cells derived from patients have been
investigated.
Although the main challenge of organs-on-chip systems is
how to best reproduce the in vivo conditions, a second chal-
lenge is how to make such a device as robust and reproduc-
ible as possible. This aspect is central in view of a wider
acceptance of those systems by cell biologists, toxicologists
and pharmacologists. The strategy followed during the devel-
opment of the present device was therefore aimed at design-
ing a system that would combine ease of handling (e.g. com-
patible with a multi-pipette), reproducible control of the
cultured conditions (the number of cells cultured on the
membrane and the defined level of mechanical strain) and
recapitulation of the main in vivo features. Such systems are
widely expected to better predict human responses to drugs
and present a great possibility of improving the selection of
drug candidates early in the drug discovery process.
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